The Incidence Rate of HIV Type-1 drug Resistance in Patients on Antiretroviral Therapy: A Nationwide Population-Based Danish Cohort Study 1999–2005
- 1 October 2008
- journal article
- research article
- Published by SAGE Publications in Antiviral Therapy
- Vol. 14 (7) , 995-1000
Abstract
Background: Newer antiretroviral treatment regimens for HIV carry a lower risk of inducing drug resistance mutations. We estimated changes in incidence rates (IRs) of new mutations in HIV-infected individuals receiving highly active antiretroviral therapy (HAART). Methods: Population-based data were obtained from the Danish HIV Cohort Study and the Danish HIV Sequence Database. We included treatment-naive patients initiating HAART after December 1997 and computed time to first drug resistance mutation, identified as new mutations detected within 1 year after a 60-day period of treatment failure (HIV RNA>1,000 copies/ml). We estimated annual IRs of new resistance mutations towards nucleoside reverse transcriptase inhibitors (NRTIs), non-NRTIs (NNRTIs) and protease inhibitors (PI), and of new specific resistance mutations. Results: A total of 1,829 individuals were observed for 7,294 person-years at risk (PYR). The IR of NRTI resistance decreased from 13.1 per 1,000 PYR (95% confidence interval [CI] 4.9–35.0) in 1999 to 3.7 (1.9–7.2) in 2004–2005 (test for trend P=0.024). The IR of NNRTI resistance decreased from 15.4 (2.2–109.6) in 1999 to 7.9 (4.6–13.6) in 2004–2005 ( P=0.077). The IR of PI resistance decreased from 7.5 (1.4–21.8) in 1999 to 2.9 (0.7–11.4) in 2002–2003 ( P=0.148). The IRs were low for specific resistance mutations, except for M184V (IR 5.6 [4.0–7.9]) and K103N (IR 8.2 [5.6–12.0]). Conclusions: The incidence of acquired drug resistance has decreased among HIV-infected patients treated with HAART in Denmark during 1999–2005.Keywords
This publication has 18 references indexed in Scilit:
- Class-Sparing Regimens for Initial Treatment of HIV-1 InfectionNew England Journal of Medicine, 2008
- The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001–2006) in PortugalRetrovirology, 2008
- Emergence of HIV-1 Drug Resistance in Previously Untreated Patients Initiating Combination Antiretroviral TreatmentA Comparison of Different Regimen TypesArchives of internal medicine (1960), 2007
- Prevalence of HIV-1 Drug Resistance in Treated PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Demographics of HIV-1 infection in Denmark: Results from the Danish HIV Cohort StudyScandinavian Journal of Infectious Diseases, 2005
- Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practiceAIDS, 2005
- NelfinavirDrugs, 2005
- Surveillance of HIV antiretroviral drug resistance in treated individuals in England: 1998-2000Journal of Antimicrobial Chemotherapy, 2004
- Human Immunodeficiency Virus Rebound after Suppression to <400 Copies/mL during Initial Highly Active Antiretroviral Therapy Regimens, according to Prior Nucleoside Experience and Duration of SuppressionThe Journal of Infectious Diseases, 2002
- Evolution of Lamivudine Resistance in Human Immunodeficiency Virus Type 1-Infected Individuals: the Relative Roles of Drift and SelectionJournal of Virology, 2000